genia tagger: 51('behaviors', 6)
('nmdar', 14)
('f2', 60)
('f3', 16)
('f5', 4)
('f1', 44)
('n\\=9\\\xe2\\\x80\\\x9310', 2)
('eaat1', 2)
('results', 4)
('ii', 1)
('receptor', 11)
('\\.01', 94)
('\\*\\*', 4)
('glutamate', 32)
('het', 8)
('group', 5)
('extrasynaptic', 4)
('data', 15)
('\\<', 148)
('receptors', 2)
('treatment\\.', 8)
('regions', 2)
('f22', 4)
('2', 336)
('f69', 4)
('\\*', 12)
('\\(', 253)
('higher', 8)
('slc1a3', 2)
('astrocytes', 2)
('metabotropic', 1)
('glast', 91)
('scores', 8)
('\\)', 253)
('-methyl-d-aspartate', 2)
('mk-801', 36)
('than', 46)
('gene', 8)
('f', 1072)
('ly379268', 70)
('\\.05', 54)
('ko', 112)
('mglu2\\/3', 24)
('promoter', 2)
('n', 2255)
('p', 927)
('mrna', 2)
('forebrain', 4)
('locomotor', 87)
('f11', 16)
('\xe2\x80\x98schizophrenia-related\xe2\x80\x99', 8)


spacy + metamap: 285('glutamate signaling', 2)
('excessive', 7)
('reversal', 6)
('numbers', 2)
('increased activity', 4)
('global', 4)
('competitive', 2)
('habituation', 6)
('neurodevelopment', 4)
('elevated', 2)
('committee', 2)
('reduced locomotor activity', 8)
('repeated measures', 2)
('therapeutic efficacy', 2)
('injection', 8)
('based', 2)
('animal care', 2)
('disturbance', 2)
('group', 5)
('antipsychotic', 11)
('conclusions', 2)
('pcp', 24)
('receptors', 2)
('majority', 2)
('symptoms', 8)
('experiment', 4)
('treatment', 64)
('instruments', 2)
('main', 22)
('uptake', 3)
('extracellular', 3)
('first', 6)
('non', 8)
('lack', 8)
('greater', 6)
('antagonism', 2)
('familiar', 16)
('males', 40)
('overall', 12)
('possible', 2)
('familiar environment', 12)
('abnormality', 2)
('pathophysiology', 5)
('photocell', 2)
('inhibition', 4)
('effects', 28)
('background', 1)
('not', 172)
('impaired', 2)
('difference', 16)
('cage', 14)
('antagonist', 8)
('areas', 2)
('loss', 13)
('glast gene', 2)
('same', 4)
('55', 2)
('phenotype', 2)
('summary', 2)
('ly379268', 70)
('either', 4)
('mrna', 2)
('activity', 99)
('standard deviation', 4)
('receptor', 11)
('mouse', 2)
('higher', 8)
('locomotor activity', 36)
('mean', 6)
('nmdar', 14)
('square', 2)
('methods', 3)
('findings', 6)
('gaba', 4)
('transient', 2)
('guidelines', 2)
('direct', 4)
('related', 8)
('sex', 66)
('relative', 18)
('individual', 10)
('neurotransmission', 2)
('result', 6)
('doses', 2)
('agonists', 8)
('home', 14)
('indirect', 2)
('subject', 2)
('individual differences', 8)
('lux', 2)
('ability', 8)
('activity levels', 4)
('monitor', 2)
('increase', 10)
('c57bl', 10)
('mediated', 10)
('genotype', 108)
('3b', 4)
('induced', 18)
('issue', 4)
('genotypes', 4)
('genetic mutation', 2)
('measures', 6)
('mglu2', 24)
('responses', 3)
('useful', 2)
('experimental procedures', 2)
('human', 4)
('residual', 4)
('release', 6)
('wt', 54)
('hypothesis', 6)
('groups', 4)
('excess', 9)
('acclimation', 4)
('post', 48)
('finding', 8)
('information technology', 2)
('receptor activation', 1)
('exhibit', 4)
('f11', 16)
('last', 99)
('agonist', 29)
('antipsychotics', 2)
('exaggerated', 9)
('31', 16)
('23', 14)
('drug', 40)
('reduced', 10)
('prior', 6)
('negative', 2)
('important', 2)
('present', 8)
('context', 2)
('mixed', 8)
('variance', 2)
('contribution', 2)
('changes', 2)
('block', 4)
('responsivity', 4)
('validation', 2)
('pre', 44)
('major', 4)
('co', 190)
('predictive', 2)
('inducing', 6)
('time point', 8)
('f2', 60)
('microdialysis', 2)
('f3', 16)
('97', 4)
('female', 24)
('68', 90)
('total', 16)
('open', 48)
('drug interaction', 12)
('dysfunction', 1)
('het', 8)
('use', 15)
('aspartate receptor', 2)
('basis', 2)
('positive', 4)
('support', 10)
('two', 4)
('1a', 6)
('1b', 4)
('m3', 2)
('vehicle', 34)
('white', 2)
('exposure', 6)
('assessment', 2)
('final', 2)
('more', 32)
('pfc', 6)
('glia', 1)
('females', 20)
('efficacy', 5)
('slc1a3', 2)
('drugs', 2)
('sufficient', 4)
('plexiglas', 2)
('astrocytes', 2)
('basal', 6)
('environmental', 4)
('interaction', 64)
('permanent', 2)
('normalized', 8)
('glast', 91)
('number', 4)
('mice', 38)
('evidence', 4)
('supplemental', 12)
('observation', 2)
('cerebellum', 2)
('distance', 26)
('novel', 58)
('animals', 2)
('third', 2)
('challenge', 20)
('psychosis', 6)
('decreased activity', 4)
('patients', 2)
('ontogeny', 2)
('behavioral', 2)
('posit', 6)
('male', 50)
('treated', 2)
('study', 4)
('cages', 2)
('statistical analysis', 2)
('behaviors', 6)
('va', 39)
('haloperidol', 33)
('mutant', 6)
('antagonists', 4)
('f5', 4)
('hyperactivity', 45)
('measure', 12)
('condition', 12)
('tests', 18)
('niaaa', 2)
('high', 12)
('neurons', 2)
('intramural research', 2)
('further', 14)
('abnormalities', 10)
('inhibitory control', 2)
('glutamate', 32)
('saline', 2)
('hippocampus', 4)
('baseline', 16)
('drug treatment', 2)
('na', 66)
('discussion', 2)
('clarification', 2)
('detail', 2)
('mechanism', 2)
('risk factor', 4)
('field', 48)
('phencyclidine', 4)
('potential', 6)
('psychotomimetics', 1)
('details', 2)
('rodents', 2)
('test', 46)
('stimulus', 2)
('tool', 2)
('30 min', 8)
('acute', 2)
('nih', 2)
('glutamate reuptake', 2)
('supplementary material', 2)
('normal', 28)
('modulation', 1)
('genotypic', 4)
('neuronal hyperexcitability', 2)
('effect', 108)
('pharmacological', 2)
('levels', 5)
('promoter', 2)
('significant', 94)
('scores', 8)
('robust', 6)
('data', 15)
('response', 29)
('recent', 5)
('increased sensitivity', 2)
('early', 2)
('lower', 4)
('glutamate transporter', 2)
('center', 8)
('consequences', 1)
('neural', 2)
('protein expression', 2)
('ko', 112)
('disease', 2)
('analysis', 20)
('materials', 1)
('cognitive symptoms', 2)
('cortex', 3)
('time', 76)
('region', 2)
('model', 12)
('clearance', 8)
('signaling', 3)


total: 315('glutamate signaling', 2)
('excessive', 7)
('reversal', 6)
('numbers', 2)
('increased activity', 4)
('global', 4)
('results', 4)
('competitive', 2)
('habituation', 6)
('neurodevelopment', 4)
('first', 6)
('elevated', 2)
('committee', 2)
('reduced locomotor activity', 8)
('repeated measures', 2)
('therapeutic efficacy', 2)
('injection', 8)
('based', 2)
('animal care', 2)
('disturbance', 2)
('group', 5)
('antipsychotic', 11)
('conclusions', 2)
('\\<', 148)
('measure', 12)
('receptors', 2)
('majority', 2)
('symptoms', 8)
('experiment', 4)
('treatment', 64)
('instruments', 2)
('main', 22)
('\\*', 12)
('extracellular', 3)
('\\(', 253)
('\\)', 253)
('non', 8)
('lack', 8)
('rodents', 2)
('impaired', 2)
('antagonism', 2)
('familiar', 16)
('males', 40)
('overall', 12)
('possible', 2)
('familiar environment', 12)
('abnormality', 2)
('pathophysiology', 5)
('metabotropic', 1)
('inhibition', 4)
('effects', 28)
('background', 1)
('not', 172)
('1b', 4)
('-methyl-d-aspartate', 2)
('difference', 16)
('cage', 14)
('antagonist', 8)
('areas', 2)
('loss', 13)
('glast gene', 2)
('23', 14)
('same', 4)
('ly379268', 70)
('phenotype', 2)
('region', 2)
('summary', 2)
('p', 927)
('either', 4)
('mrna', 2)
('forebrain', 4)
('standard deviation', 4)
('mouse', 2)
('30 min', 8)
('locomotor activity', 36)
('mean', 6)
('nmdar', 14)
('square', 2)
('methods', 3)
('findings', 6)
('gaba', 4)
('n\\=9\\\xe2\\\x80\\\x9310', 2)
('guidelines', 2)
('direct', 4)
('related', 8)
('sex', 66)
('relative', 18)
('individual', 10)
('neurotransmission', 2)
('result', 6)
('doses', 2)
('agonists', 8)
('home', 14)
('indirect', 2)
('\\*\\*', 4)
('subject', 2)
('individual differences', 8)
('psychosis', 6)
('extrasynaptic', 4)
('ability', 8)
('activity levels', 4)
('monitor', 2)
('increase', 10)
('f22', 4)
('mediated', 10)
('tests', 18)
('genotype', 108)
('cortex', 3)
('3b', 4)
('induced', 18)
('issue', 4)
('genotypes', 4)
('genetic mutation', 2)
('measures', 6)
('mglu2', 24)
('responses', 3)
('normalized', 8)
('experimental procedures', 2)
('human', 4)
('activity', 99)
('residual', 4)
('release', 6)
('wt', 54)
('hypothesis', 6)
('groups', 4)
('excess', 9)
('acclimation', 4)
('post', 48)
('finding', 8)
('information technology', 2)
('receptor activation', 1)
('exhibit', 4)
('male', 50)
('last', 99)
('agonist', 29)
('55', 2)
('exaggerated', 9)
('31', 16)
('\\.05', 54)
('drug', 40)
('\\.01', 94)
('prior', 6)
('negative', 2)
('important', 2)
('present', 8)
('context', 2)
('mixed', 8)
('variance', 2)
('contribution', 2)
('gene', 8)
('changes', 2)
('pcp', 24)
('block', 4)
('responsivity', 4)
('validation', 2)
('pre', 44)
('major', 4)
('co', 190)
('va', 39)
('predictive', 2)
('inducing', 6)
('time point', 8)
('haloperidol', 33)
('microdialysis', 2)
('mutant', 6)
('receptor', 11)
('female', 24)
('68', 90)
('total', 16)
('open', 48)
('drug interaction', 12)
('dysfunction', 1)
('het', 8)
('use', 15)
('antipsychotics', 2)
('c57bl', 10)
('aspartate receptor', 2)
('basis', 2)
('positive', 4)
('support', 10)
('two', 4)
('reduced', 10)
('1a', 6)
('2', 336)
('m3', 2)
('vehicle', 34)
('white', 2)
('exposure', 6)
('assessment', 2)
('final', 2)
('more', 32)
('pfc', 6)
('glia', 1)
('females', 20)
('97', 4)
('efficacy', 5)
('transient', 2)
('drugs', 2)
('sufficient', 4)
('plexiglas', 2)
('decreased activity', 4)
('acute', 2)
('basal', 6)
('environmental', 4)
('interaction', 64)
('permanent', 2)
('signaling', 3)
('glast', 91)
('number', 4)
('mice', 38)
('niaaa', 2)
('mk-801', 36)
('than', 46)
('supplemental', 12)
('observation', 2)
('cerebellum', 2)
('distance', 26)
('novel', 58)
('animals', 2)
('third', 2)
('f', 1072)
('risk factor', 4)
('uptake', 3)
('challenge', 20)
('neural', 2)
('promoter', 2)
('n', 2255)
('patients', 2)
('ontogeny', 2)
('behavioral', 2)
('posit', 6)
('\xe2\x80\x98schizophrenia-related\xe2\x80\x99', 8)
('f11', 16)
('treated', 2)
('study', 4)
('cages', 2)
('statistical analysis', 2)
('behaviors', 6)
('f1', 44)
('f2', 60)
('f3', 16)
('antagonists', 4)
('f5', 4)
('hyperactivity', 45)
('eaat1', 2)
('condition', 12)
('astrocytes', 2)
('disease', 2)
('ii', 1)
('neurons', 2)
('intramural research', 2)
('further', 14)
('abnormalities', 10)
('inhibitory control', 2)
('glutamate', 32)
('greater', 6)
('saline', 2)
('high', 12)
('hippocampus', 4)
('baseline', 16)
('drug treatment', 2)
('na', 66)
('discussion', 2)
('clarification', 2)
('detail', 2)
('mechanism', 2)
('treatment\\.', 8)
('regions', 2)
('field', 48)
('phencyclidine', 4)
('potential', 6)
('psychotomimetics', 1)
('details', 2)
('f69', 4)
('test', 46)
('stimulus', 2)
('tool', 2)
('evidence', 4)
('higher', 8)
('nih', 2)
('glutamate reuptake', 2)
('supplementary material', 2)
('normal', 28)
('modulation', 1)
('genotypic', 4)
('neuronal hyperexcitability', 2)
('effect', 108)
('pharmacological', 2)
('levels', 5)
('significant', 94)
('scores', 8)
('robust', 6)
('data', 15)
('response', 29)
('recent', 5)
('increased sensitivity', 2)
('early', 2)
('lower', 4)
('clearance', 8)
('center', 8)
('consequences', 1)
('photocell', 2)
('protein expression', 2)
('ko', 112)
('mglu2\\/3', 24)
('analysis', 20)
('lux', 2)
('materials', 1)
('cognitive symptoms', 2)
('useful', 2)
('time', 76)
('locomotor', 87)
('model', 12)
('glutamate transporter', 2)
('slc1a3', 2)
